Biotechnology
Eirgenix Receives Approval from Japan's PMDA
TAIPEI, Feb. 14, 2020 /PRNewswire/ -- EirGenix, Inc. (6589, TT) had undertaken the transfer of drug substance manufacturing of a marketed drug from a Japanese pharmaceutical company and has since fulfilled all the regulatory requirements necessary to complete the manufacturing site transfer. The ...
2020-02-14 15:14
2829
Sihuan Pharmaceutical Accelerates Product Expansion in Digestive System and Liver Related Diseases
HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd.(HKEX: 0460) ("Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the progress achieved by the Group in the research and development of drugs for treati...
2020-02-14 10:35
7505
George Clinical Names James Cheong Chief Executive Officer
SYDNEY, Feb. 13, 2020 /PRNewswire/ -- George Clinical, a global scientifically-backed clinical research organization, has namedJames Cheong to the role of Chief Executive Officer. Cheong was hired as Chief Operating Officer at the beginning of 2019 and has overseen substantial growth of the bu...
2020-02-13 01:00
1848
Sirtex Medical announces collaboration with MIM Software Inc.
Partnership advances innovation and increases precision of liver-directed oncology therapies for patients WOBURN, Massachusetts, Feb. 12, 2020 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced a collaboration with MIM Software Inc., a lead...
2020-02-12 22:00
1702
IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs
MENLO PARK, California, Feb. 12, 2020 /PRNewswire/ -- IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in im...
2020-02-12 03:25
2311
Genomenon Commended by Frost & Sullivan for Advancing Clinical Genomics Interpretation and Personalized Medicine with Its Mastermind Platform
The company's content-rich genomic database platform and AI-driven processing help mitigate early-stage genomic translational research challenges SANTA CLARA, California, Feb. 11, 2020 /PRNewswire/ -- Based on its recent analysis of the global clinical genomics interpretation market, Frost & Sul...
2020-02-11 22:00
1306
Carbiotix Launches Second Generation Diagnostic Platform
STOCKHOLM, Feb. 11, 2020 /PRNewswire/ -- Carbiotix (publ) ("Carbiotix") announces today that the company has launched its second generation diagnostic platform for gut health based on Next Generation Sequencing (NGS). The company will now offer a NGS test with three samples as a standard and at a...
2020-02-11 16:11
847
Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020
PHILADELPHIA and LONDON, Feb. 10, 2020 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced the launch of its annual Cortellis "Drugs to Watch " list, which identifies 11 new...
2020-02-10 21:42
5119
Nanoform Establishes US Subsidiary
HELSINKI, Feb. 10, 2020 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, has established NanoformUSA Inc., a wholly owned subsidiary in the US. This is a natural progression for the company as it continues to increase the impact of its award-winning nanonization™ te...
2020-02-10 15:26
859
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...
2020-02-06 19:30
12711
French Biotech TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Hafnia alvei HA4597™ on the Weight Loss Thanks to Regulation of Appetite
PARIS, Feb. 6, 2020 /PRNewswire/ -- TargEDys® announces the successful completion of its 3 months, randomized, double blind, placebo-controlled, multicentric clinical study carried out on 229 subjects and evaluating the efficacy ofHafnia alvei HA4597™ in the weight loss by regulation of the appe...
2020-02-06 09:07
2482
Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer
MUMBAI, India, Feb. 6, 2020 /PRNewswire/ -- A new study
2020-02-06 08:00
2414
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...
2020-02-03 21:00
2482
GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma
- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...
2020-02-03 17:00
9224
Oxford Nanopore Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance
OXFORD, England, Feb. 3, 2020 /PRNewswire/ -- Following extensive support of, and collaboration with, public health professionals inChina, Oxford Nanopore has shipped an additional 200 MinION sequencers and related consumables toChina . These will be used to support the ongoing surveillance of the...
2020-02-03 05:20
2698
Coronavirus: New Gear Offers Protection For Patients And Healthcare Workers
MIAMI, Jan. 31, 2020 /PRNewswire/ -- In the ongoing war against Coronavirus, a new technology can provide much-needed protection and benefits for patients and healthcare workers.Radiation Shield Technologies' Demron Chemical Biological Radiological and Nuclear suits have patented thermal conducti...
2020-01-31 07:02
2264
Inovio Collaborating With Beijing Advaccine To Advance INO-4800 Vaccine Against New Coronavirus In China
Agreement will facilitate clinical trial translations in China PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development inChina of INO-4800, Inovio'...
2020-01-30 19:00
4325
Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell's Gene Editing Platform and Oncology Product Portfolio
CAMBRIDGE, England and MILPITAS, Calif., Jan. 30, 2020 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce the asset purchase of the gene editing platform and oncology product portfolio of Applied StemCell, Inc. (ASC) for life science res...
2020-01-30 15:00
1200
MiRXES collaborates with NUS and DxD Hub to move Singapore to the forefront of global microRNA research and application
SINGAPORE, Jan. 29, 2020 /PRNewswire/ -- MiRXES, a leading Singaporean biotech start-up in microRNA[1] (miRNA) technology and diagnostics, collaborated with NUS and DxD Hub to mark the tenth year of miRNA research and clinical translation inSingapore. These organizations jointly led a non-coding ...
2020-01-29 10:00
2092
WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
SHANGHAI, Jan. 29, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of multipl...
2020-01-29 10:00
3361
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 308 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
MediSun Energy Joins the Abu Dhabi Sustainable Finance Declaration, Reinforcing Commitment to Sustainable Solutions in the UAE
[Picked up by 290 media titles]
2024-12-18 15:35
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
8883
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
8558
